Paul Maier
Director/Board Member chez ETON PHARMACEUTICALS, INC.
Fortune : 226 766 $ au 31/03/2024
Profil
Mr. Paul V.
Maier is an Independent Director at Ambrx Biopharma Cayman, Inc., an Independent Non-Executive Director at Small Pharma, Inc., an Independent Non-Executive Director at 4D Pharma Plc, an Independent Director at Eton Pharmaceuticals, Inc., an Independent Director at International Stem Cell Corp., a Chairman at Lackey Clinic and an Executive Partner at Mason School of Business of The College of William & Mary.
He is on the Board of Directors at Ambrx Biopharma Cayman, Inc., Ambrx, Inc., Small Pharma, Inc., 4D Pharma Plc, Eton Pharmaceuticals, Inc., Biological Dynamics, Inc. and International Stem Cell Corp.
Mr. Maier was previously employed as an Independent Director by Ambrx Biopharma, Inc., an Independent Director by Ritter Pharmaceuticals, Inc., an Independent Director by MabVax Therapeutics, Inc., an Independent Director by Apricus Biosciences, Inc., a Chief Financial Officer by Sequenom, Inc., an Independent Director by Talon Therapeutics, Inc., an Independent Director by PURE Bioscience, Inc., a Chief Financial Officer & Senior Vice President by Ligand Pharmaceuticals, Inc., a Vice President-Finance by DFS West, a Treasurer & Vice President by Valeant Pharmaceuticals International Corp., a VP-DFW West Finance by DFS Group LP (Hawaii), and a Vice President-Finance by SPI Pharmaceuticals, Inc. He also served on the board at Telik, Inc. and MabVax Therapeutics Holdings, Inc. He received his undergraduate degree from The Pennsylvania State University and an MBA from Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 13/02/2024 | 59 745 ( 0,23% ) | 224 044 $ | 31/03/2024 | |
| 30/06/2023 | 32 802 ( 0,41% ) | 2 723 $ | 31/03/2024 |
Postes actifs de Paul Maier
| Sociétés | Poste | Début |
|---|---|---|
| INTERNATIONAL STEM CELL CORPORATION | Director/Board Member | 01/07/2007 |
| ETON PHARMACEUTICALS, INC. | Director/Board Member | 14/09/2017 |
| 4D PHARMA PLC | Director/Board Member | 01/03/2021 |
| SMALL PHARMA INC. | Director/Board Member | 18/11/2021 |
| AMBRX INC | Director/Board Member | 01/02/2022 |
| Lackey Clinic | Chairman | - |
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Director/Board Member | 07/02/2022 |
| Mason School of Business of The College of William & Mary | Corporate Officer/Principal | - |
Biological Dynamics, Inc.
 Biological Dynamics, Inc. Medical DistributorsDistribution Services Biological Dynamics, Inc. engages in the development of cancer diagnostic solutions for labs and homes. Its platform offers a way to isolate cell-free nanoparticles and macromolecules directly from whole blood, serum, or plasma. The firm also develops a suite of oncology tests for early cancer detection, treatment response, and recurrence monitoring. The company was founded by Raj Krishnan, Edward D. Truitt III, Michael J. Heller, Roy Lefkowitz, and David Charlot in 2008 and is headquartered in San Diego, CA. | Director/Board Member | 01/11/2014 |
Anciens postes connus de Paul Maier
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Paul Maier
| The Pennsylvania State University | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 6 |
|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| PURE BIOSCIENCE, INC. | Process Industries |
| INTERNATIONAL STEM CELL CORPORATION | Health Technology |
| 4D PHARMA PLC | Health Technology |
| ETON PHARMACEUTICALS, INC. | Health Technology |
| SMALL PHARMA INC. | Retail Trade |
| Entreprise privées | 15 |
|---|---|
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Health Technology |
Apricus Biosciences, Inc.
 Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | Health Technology |
Sequenom, Inc.
 Sequenom, Inc. Medical SpecialtiesHealth Technology Sequenom, Inc. engages in the provision of early patient management information. It develops and commercializes molecular diagnostic testing services that serve women's health and oncology markets. The company was founded by Hubert Koester and Charles R. Cantor in October 09, 1996 and is headquartered in Burlington, NC. | Health Technology |
Telik, Inc.
 Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA. | Health Technology |
MabVax Therapeutics, Inc.
 MabVax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology MabVax Therapeutics, Inc. developed and commercialized immunotherapeutics for the treatment of cancer. The company was founded in 2006 and is headquartered in San Diego, CA. | Health Technology |
Ritter Pharmaceuticals, Inc.
 Ritter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat digestive disorders and gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. The company was founded by Andrew J. Ritter and Ira E. Ritter on March 29, 2004 and is headquartered in Los Angeles, CA. | Health Technology |
| SPI Pharmaceuticals, Inc. | Health Technology |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Health Technology |
Ambrx, Inc.
 Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
DFS Group LP (Hawaii)
 DFS Group LP (Hawaii) Apparel/Footwear RetailRetail Trade DFS Group LP retails beauty and fashion products. It operates as a retailer of duty-free merchandise which specializes in catering to international travelers. The company was founded in 1986 and is headquartered in Honolulu, HI. | Retail Trade |
| DFS West | |
Biological Dynamics, Inc.
Biological Dynamics, Inc. Medical DistributorsDistribution Services Biological Dynamics, Inc. engages in the development of cancer diagnostic solutions for labs and homes. Its platform offers a way to isolate cell-free nanoparticles and macromolecules directly from whole blood, serum, or plasma. The firm also develops a suite of oncology tests for early cancer detection, treatment response, and recurrence monitoring. The company was founded by Raj Krishnan, Edward D. Truitt III, Michael J. Heller, Roy Lefkowitz, and David Charlot in 2008 and is headquartered in San Diego, CA. | Distribution Services |
MabVax Therapeutics Holdings, Inc.
 MabVax Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology MabVax Therapeutics Holdings, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. The company was founded on July 8, 2014 and is headquartered in San Diego, CA. | Health Technology |
| Lackey Clinic | |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Health Technology |
